Skip to content

Clinical trials

Completed Phase 1/2 Demyelinating Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Phase: Phase 1/2 Status: Completed Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud1
Banc de Sang i Teixits1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases2
Demyelinating Diseases2
Multiple Sclerosis2
Nervous System Diseases2
Autoimmune Diseases of the Nervous System1
Demyelinating Autoimmune Diseases, CNS1
Immune System Diseases1
Multiple Sclerosis, Chronic Progressive1
Multiple Sclerosis, Relapsing-Remitting1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.